The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| SNN | +27.48% | +8.01% | +1.55% | +598% |
| S&P | +15.06% | +95.03% | +14.29% | +374% |
Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. It operates through the following segments: Orthopaedics; Sports Medicine and ENT; and Advanced Wound Management. The Orthopaedics and Sports Medicine and ENT segment consists of the following businesses: knee implants, hip implants, other reconstruction, trauma, sports medicine joint repair, arthroscopic enabling technologies and ENT. The Advanced Wound Management segment comprises advanced wound care, advanced wound bioactives and advanced wound devices businesses. The company was founded in 1856 and is headquartered in Watford, the United Kingdom.
The pandemic hit Zimmer, Smith+Nephew, and Stryker hard -- but they'll soon rise again.
Some of the biggest medical device companies' stocks have dropped to attractive prices due to the current COVID-19 pandemic.
Currently no data to display
Currently no data to display.
Currently no data to display.
| Metric | YoY Change |
|---|
SNN earnings call for the period ending September 30, 2021.
SNN earnings call for the period ending April 3, 2021.
SNN earnings call for the period ending December 31, 2020.
SNN earnings call for the period ending September 30, 2020.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
